Showing results (1401-1410 of 5,275) with videos related to

Sort By:
Pageof 528
Oncology|February 3, 2018
Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-AnalysisFausto Petrelli, Raffaele Ardito, Antonio Ghidini, et al.
Oncology|January 12, 2018
The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian CancerHeidi Kemiläinen, Kaisa Huhtinen, Annika Auranen, et al.
Oncology|March 5, 2018
A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung CancerCheol-Kyu Park, In-Jae Oh, Yoo-Duk Choi, et al.
Oncology|March 7, 2018
Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database AnalysisMichael S Broder, Beilei Cai, Eunice Chang, et al.
Oncology|March 7, 2018
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with TrabectedinBruno Vincenzi, Giuseppe Badalamenti, Grazia Armento, et al.
Oncology|February 15, 2018
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTIMarkus Kieler, Leonhard Müllauer, Oskar Koperek, et al.
Oncology|November 18, 2017
Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast CancerTakuya Kawahara, Kojiro Shimozuma, Takeru Shiroiwa, et al.
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.
Oncology|March 8, 2018
Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate CancerLi Rebekah Feng, Alexandra Espina, Leorey N Saligan
Oncology|January 1, 1988
Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group StudyS Eckhardt, E Juhos, I Hindy, et al.
Pageof 528